Dimensional Fund Advisors LP Wave Life Sciences Ltd. Transaction History

Dimensional Fund Advisors LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$2.37 - $4.28 $70,071 - $126,542	-29,566 Reduced 65.79%	15,371 $56,000
Q1 2022 May 13, 2022	SELL	$2.0 - $3.28 $5,904 - $9,682	-2,952 Reduced 6.16%	44,937 $90,000
Q4 2021 Feb 09, 2022	SELL	$3.14 - $5.15 $16,199 - $26,568	-5,159 Reduced 9.73%	47,889 $150,000
Q3 2021 Nov 12, 2021	SELL	$4.89 - $7.12 $367,899 - $535,673	-75,235 Reduced 58.65%	53,048 $260,000
Q2 2021 Aug 12, 2021	SELL	$5.65 - $7.47 $194,947 - $257,744	-34,504 Reduced 21.2%	128,283 $854,000
Q1 2021 May 14, 2021	BUY	$5.61 - $12.01 $843,211 - $1.81 Million	150,305 Added 1204.17%	162,787 $913,000
Q4 2020 Feb 25, 2021	BUY	$6.99 - $9.26 $87,249 - $115,583	12,482 New	12,482 $98,000

196

123M

323K

279K

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $939M
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.